Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Feb 29, 2016
Insider Transaction Report
Form 4
Celniker Abbie
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-02-25+113,250→ 113,250 totalExercise: $0.28Exp: 2026-02-24→ Common Stock (113,250 underlying) - Award
Stock Option (Right to Buy)
2016-02-25+90,000→ 90,000 totalExercise: $0.28Exp: 2026-02-24→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]This option was granted February 25, 2016 and vests over four years in equal quarterly installments, with the first installment vesting on March 31, 2016.
- [F2]This option was granted on February 25, 2016 and vests over two years in equal monthly installments, with the first installment vesting on March 25, 2016.